Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33466 | 91 | 17.3 | 22% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TACTIVIN | Author keyword | 3 | 50% | 4% | 4 |
2 | AMIRIDIN | Author keyword | 1 | 50% | 1% | 1 |
3 | CADDIES | Author keyword | 1 | 50% | 1% | 1 |
4 | CONDITIONED PASSIVE AVOIDANCE REFLEX | Author keyword | 1 | 50% | 1% | 1 |
5 | DIRECT CURRENT POTENTIALS OF THE BRAIN | Author keyword | 1 | 50% | 1% | 1 |
6 | RAT PIAL MICROVESSELS | Author keyword | 1 | 50% | 1% | 1 |
7 | HIPPOCAMPAL FIELDS | Author keyword | 0 | 33% | 1% | 1 |
8 | AVOIDANCE REACTION | Author keyword | 0 | 18% | 2% | 2 |
9 | NEOCORTICAL LAYERS | Author keyword | 0 | 25% | 1% | 1 |
10 | PHARMACOL PSYCHOPHARMACOL | Address | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TACTIVIN | 3 | 50% | 4% | 4 | Search TACTIVIN | Search TACTIVIN |
2 | AMIRIDIN | 1 | 50% | 1% | 1 | Search AMIRIDIN | Search AMIRIDIN |
3 | CADDIES | 1 | 50% | 1% | 1 | Search CADDIES | Search CADDIES |
4 | CONDITIONED PASSIVE AVOIDANCE REFLEX | 1 | 50% | 1% | 1 | Search CONDITIONED+PASSIVE+AVOIDANCE+REFLEX | Search CONDITIONED+PASSIVE+AVOIDANCE+REFLEX |
5 | DIRECT CURRENT POTENTIALS OF THE BRAIN | 1 | 50% | 1% | 1 | Search DIRECT+CURRENT+POTENTIALS+OF+THE+BRAIN | Search DIRECT+CURRENT+POTENTIALS+OF+THE+BRAIN |
6 | RAT PIAL MICROVESSELS | 1 | 50% | 1% | 1 | Search RAT+PIAL+MICROVESSELS | Search RAT+PIAL+MICROVESSELS |
7 | HIPPOCAMPAL FIELDS | 0 | 33% | 1% | 1 | Search HIPPOCAMPAL+FIELDS | Search HIPPOCAMPAL+FIELDS |
8 | AVOIDANCE REACTION | 0 | 18% | 2% | 2 | Search AVOIDANCE+REACTION | Search AVOIDANCE+REACTION |
9 | NEOCORTICAL LAYERS | 0 | 25% | 1% | 1 | Search NEOCORTICAL+LAYERS | Search NEOCORTICAL+LAYERS |
10 | SPEED OF READING | 0 | 25% | 1% | 1 | Search SPEED+OF+READING | Search SPEED+OF+READING |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REVERSIBLE DISTURBANCE | 1 | 100% | 2% | 2 |
2 | AVOIDANCE REACTION | 1 | 50% | 1% | 1 |
3 | TACTIVIN | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOL PSYCHOPHARMACOL | 0 | 25% | 1.1% | 1 |
2 | HIGHER NERVOUS ACTIV | 0 | 13% | 1.1% | 1 |
3 | BIOL EVOLUT MEMORY MECHANISMS | 0 | 100% | 1.1% | 1 |
4 | EVOLUT MEMORY MECH | 0 | 100% | 1.1% | 1 |
5 | HIGHER NERVOUS ACTIV NUEROPHYSIOL | 0 | 100% | 1.1% | 1 |
6 | MOL IMMUNOL BIOCHEM | 0 | 100% | 1.1% | 1 |
7 | P ANIN INWARD WATERS BIOL | 0 | 100% | 1.1% | 1 |
8 | PHYSCOCHEM MED | 0 | 100% | 1.1% | 1 |
9 | RUSSIAN MINIST HLTH SOCIAL PROTECT | 0 | 100% | 1.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000226837 | AXIOLOGICAL ORIENTATION//CATECHOLAMINE CONCENTRATION//PERSONALITY SENSE |
2 | 0.0000182651 | NEUROTROPIN//SART STRESS//DESCENDING PAIN INHIBITORY PATHWAY |
3 | 0.0000134810 | PHOSPHOLIPIDS COMPOSITION//LIVER INDEX//AGING ASSOCIATED DISEASES |
4 | 0.0000126799 | ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA//HIGHER NERVOUS ACT NEUROPHYSIOL//ANIMAL HYPNOSIS |
5 | 0.0000122887 | AMYGDALOHIPPOCAMPAL AREA//GLUCOSE MONITORING NEURONS//MEDIODORSAL PREFRONTAL CORTEX |
6 | 0.0000111449 | NEFIRACETAM//DM 9384//ANIRACETAM |
7 | 0.0000109318 | NOOPEPT//CYCLOPROLYLGLYCINE//GVS 111 |
8 | 0.0000106460 | CHOICE OF REINFORCEMENT//EXPT MODELS//INDIVIDUAL TYPOLOGICAL FEATURES OF BEHAVIOR |
9 | 0.0000086265 | PYRIDO1 2 APYRIMIDINES//4H PYRIDO1 2 APYRIMIDINE//PYRIDO1 2 APYRIMIDIN 2 ONES |
10 | 0.0000082500 | PERINATAL ASPHYXIA//NEONATAL ANOXIA//PROGRAMME MOL CLIN PHARMACOL |